Our results showed that down-regulation of S1PR1 or S1PR3, but not S1PR2, effectively inhibited S1P-induced VEGF, IL-8 and IL-6 secretion in ovarian cancer cells. Here, S1PR3 is linked to ovarian carcinoma.